To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2648 | Icpd62 |
Novel inhibitor of heat shock protein 90 (Hsp90), demonstrating anticancer activity against colorectal, osteosarcoma and cervical cancer cell lines
More description
|
|
| DCC2647 | Icl-sirt078 |
Novel highly selective, substrate-competitive SIRT2 inhibitor, displaying a significant neuroprotective effect in a lactacystin-induced model of Parkinsonian neuronal cell death in the N27 cell line
More description
|
|
| DCC2646 | Icl-ccic-0019 |
Novel potent and selective inhibitor of choline kinase alpha (CHKA)
More description
|
|
| DCC2645 | Iclaprim |
Novel selective bacterial dihydrofolate inhibitor, antibiotic, actively against Gram positive organisms
More description
|
|
| DCC2644 | Ici-56780 |
Antimalarial agent, displaying blood schizonticidal activity against P.berghei
More description
|
|
| DCC2643 | Ici-185282 |
Potent thromboxane receptor antagonist
More description
|
|
| DCC2642 | icec0943 |
Novel selective inhibitor of CDK7
More description
|
|
| DCC2641 | Ical-36 |
Novel inhibitor of CALP, exhibiting affinity of 22.6 ± 8.0 μM for CALP and no interaction with the NHERF PDZ domains
More description
|
|
| DCC2640 | Icagen-4 |
Inhibitor of voltage-gated K(+) (Kv) channels Kv1.3 and Kv1.5
More description
|
|
| DCC2639 | ica-27243 |
Neuronal Kv7 potassium channel activator
More description
|
|
| DCC2638 | Ic2418 |
MmpL3 inhibitor, being active against drug-resistant Mycobacterium tuberculosis
More description
|
|
| DCC2637 | Ibs399024 |
Novel HDAC6-selective inhibitor
More description
|
|
| DCC2636 | Ibrutinib-bfl |
Novel fluorescent irreversible inhibitor of Bruton's tyrosine kinase (BTK)
More description
|
|
| DCC2635 | Ibpr002 |
Novel Aurora kinase inhibitor, revealing mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules
More description
|
|
| DCC2634 | Ibpr001 Hydrochloride |
Novel Aurora kinase inhibitor
More description
|
|
| DCC2633 | Ibl-302 |
First-in-class triple-acting PIM/PI3K/mTOR inhibitor, demonstrating single-agent, anti-tumour efficacy in suppression of pAKT, pmTOR and pBAD in the SKBR-3, BT-474 and HCC-1954 HER2+/PIK3CA-mutated cell lines
More description
|
|
| DCC2632 | Ibe-667 |
Novel activator of LFA-1-ICAM-1 binding
More description
|
|
| DCC2631 | Iaxo-101 |
Novel inhibitor of the cluster of differentiation 14 innate immunity pathway
More description
|
|
| DCC2630 | Iap-in-1 |
Novel antagonist of IAP (inhibitor of apoptosis protein)
More description
|
|
| DCC2629 | Ianthelliformisamine C Tfa Salt |
Antibiotic enhancer against resistant Gram-negative bacteria
More description
|
|
| DCC2628 | Ianthelliformisamine B Tfa Salt |
Antibiotic enhancer against resistant Gram-negative bacteria
More description
|
|
| DCC2627 | Ianthelliformisamine A Tfa Salt |
Antibiotic enhancer against resistant Gram-negative bacteria
More description
|
|
| DCC2626 | Ianthellamide A |
Selective kynurenine-3-hydroxylase inhibitor
More description
|
|
| DCC2625 | Iag-10 |
Novel potent and selective inhibitor of human DNA polymerase kappa (hpol κ)
More description
|
|
| DCC2624 | Hz-ma Hybrid 11b |
Novel potent and selective inhibitor of fat mass obesity-associated protein (FTO), being selectively over alkylation repair homologue 5 (ALKBH5), another DNA/RNA demethylase
More description
|
|
| DCC2623 | Hys-32 |
Novel analogue of combretastatin A-4, enhancing connexin43 expression
More description
|
|
| DCC2622 | Hymenidin |
Natural antagonist of serotonergic receptors and inhibitor of CDK5/p25 and GSK-3ß
More description
|
|
| DCC2621 | Hydroxytriolein |
Novel anticancer agent, inhibiting lung cancer cell proliferation via a PKCa and ERK1/2 dependent mechanism
More description
|
|
| DCC2620 | Hydroxymatairesinol |
Natural antioxidant and anti-cancer agent, blocking the MAPK/NF-κB and activating Nrf2/HO-1
More description
|
|
| DCC2619 | Hydroxyellipticine-1a |
Novel selective r(CGG)exp probe, improving pre-mRNA splicing defects, inhibiting formation of nuclear inclusions and RANT in a FXTAS cellular model
More description
|
|